Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is -51.53% lower on its value in year-to-date trading and has touched a low of $6.76 and a high of $130.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNXP stock was last observed hovering at around $35.17 in the last trading session, with the day’s gains setting it 0.31%.
Currently trading at $35.48, the stock is -0.84% and 19.85% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.28 million and changing 0.88% at the moment leaves the stock 59.98% off its SMA200. TNXP registered 7.58% gain for a year compared to 6-month gain of -1.47%. The firm has a 50-day simple moving average (SMA 50) of $29.6028 and a 200-day simple moving average (SMA200) of $22.19055.
The stock witnessed a -12.29% loss in the last 1 month and extending the period to 3 months gives it a 104.03%, and is -0.17% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.00% over the week and 8.80% over the month.
Tonix Pharmaceuticals Holding Corp (TNXP) has around 81 employees, a market worth around $261.03M and $10.04M in sales. Profit margin for the company is -1313.87%. Distance from 52-week low is 424.85% and -72.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-73.00%).
with sales reaching $2.6M over the same period.The EPS is expected to grow by 93.08% this year, but quarterly earnings will post 20.46% year-over-year. Quarterly sales are estimated to grow 17.75% in year-over-year returns.
32.0 institutions hold shares in Tonix Pharmaceuticals Holding Corp (TNXP), with institutional investors hold 7.04% of the company’s shares. The shares outstanding are 7.36M, and float is at 7.35M with Short Float at 15.37%. Institutions hold 7.03% of the Float.
The top institutional shareholder in the company is PRUDENTIAL FINANCIAL INC with over 97707.0 shares valued at $68141.0. The investor’s holdings represent 0.0239 of the TNXP Shares outstanding. As of 2024-06-30, the second largest holder is ALYESKA INVESTMENT GROUP, L.P. with 62500.0 shares valued at $43588.0 to account for 0.0153 of the shares outstanding. The other top investors are ACADIAN ASSET MANAGEMENT LLC which holds 57762.0 shares representing 0.0141 and valued at over $39000.0, while VANGUARD GROUP INC holds 0.0062 of the shares totaling 25395.0 with a market value of $17710.0.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Activity
The most recent transaction is an insider purchase by LEDERMAN SETH, the company’s Chief Executive Officer. SEC filings show that LEDERMAN SETH bought 4,000 shares of the company’s common stock on May 15 ’25 at a price of $21.55 per share for a total of $86200.0. Following the purchase, the insider now owns 4005.0 shares.
